Drug
Bk1803
Bk1803: highest development phase Phase 3, developed by Tanabe Pharma Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Tanabe Pharma Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| BK1803 NCT07793513 | Phase 3 | Pertussis |
Latest
No recent events.
Follow Bk1803 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.